- Effect of subcutaneously administered interferon β-1a on disease activity in patients with clinically isolated syndrome - ATRACT observational study2019 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- A comparison of efficacy of subcutaneous interferon beta-1a 44 mu g, dimethyl fumarate and fingolimod in the real-life clinical practise - a multicenter observational study2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Coping with flu-like symptoms and injection site reactions in the treatment subcutaneous interferon beta-1a od multiple sclerosis2014 | Faculty of Medicine in Pilsen
- Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event2013 | First Faculty of Medicine
- Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes2014 | First Faculty of Medicine
- Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients2016 | First Faculty of Medicine